These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28744388)

  • 1. Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases.
    Mastboom MJL; Verspoor FGM; Gelderblom H; van de Sande MAJ
    Case Rep Orthop; 2017; 2017():7402570. PubMed ID: 28744388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
    Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
    Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologically benign metastasizing tenosynovial giant cell tumor mimicking metastatic malignancy: A case report and review of literature.
    Chen EL; de Castro CM; Hendzel KD; Iwaz S; Kim MA; Valeshabad AK; Shokouh-Amiri M; Xie KL
    Radiol Case Rep; 2019 Aug; 14(8):934-940. PubMed ID: 31193787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasizing tenosynovial giant cell tumour, diffuse type/pigmented villonodular synovitis.
    Righi A; Gambarotti M; Sbaraglia M; Frisoni T; Donati D; Vanel D; Dei Tos AP
    Clin Sarcoma Res; 2015; 5():15. PubMed ID: 26052431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis.
    Abdul-Karim FW; el-Naggar AK; Joyce MJ; Makley JT; Carter JR
    Hum Pathol; 1992 Jul; 23(7):729-35. PubMed ID: 1319390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.
    Martin RC; Osborne DL; Edwards MJ; Wrightson W; McMasters KM
    Oncol Rep; 2000; 7(2):413-9. PubMed ID: 10671695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
    Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
    Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of Illness Associated with Tenosynovial Giant Cell Tumors.
    Burton TM; Ye X; Parker ED; Bancroft T; Healey J
    Clin Ther; 2018 Apr; 40(4):593-602.e1. PubMed ID: 29580718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of tenosynovial giant cell tumour of the foot and ankle.
    Spierenburg G; Lancaster ST; van der Heijden L; Mastboom MJL; Gelderblom H; Pratap S; van de Sande MAJ; Gibbons CLMH
    Bone Joint J; 2021 Apr; 103-B(4):788-794. PubMed ID: 33789469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life.
    Mastboom MJ; Planje R; van de Sande MA
    Interact J Med Res; 2018 Feb; 7(1):e4. PubMed ID: 29475829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
    Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
    Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors.
    Palmerini E; Staals EL; Maki RG; Pengo S; Cioffi A; Gambarotti M; Picci P; Daolio PA; Parafioriti A; Morris C; Antonescu CR; Gronchi A; Casali PG; Donati DM; Ferrari S; Stacchiotti S
    Eur J Cancer; 2015 Jan; 51(2):210-7. PubMed ID: 25465190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of diffuse-type tenosynovial giant cell tumour in the knee: a guide for diagnosis and treatment response assessment.
    Spierenburg G; Suevos Ballesteros C; Stoel BC; Navas Cañete A; Gelderblom H; van de Sande MAJ; van Langevelde K
    Insights Imaging; 2023 Feb; 14(1):22. PubMed ID: 36725759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis.
    Brahmi M; Vinceneux A; Cassier PA
    Curr Treat Options Oncol; 2016 Feb; 17(2):10. PubMed ID: 26820289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
    Cassier PA; Gelderblom H; Stacchiotti S; Thomas D; Maki RG; Kroep JR; van der Graaf WT; Italiano A; Seddon B; Dômont J; Bompas E; Wagner AJ; Blay JY
    Cancer; 2012 Mar; 118(6):1649-55. PubMed ID: 21823110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetabular Reconstruction in a Rare Case of Ligamentum Teres Tenosynovial Giant Cell Tumour (TGCT) Causing Extensive Destruction.
    Douvlis G; Tsiridis CA; Gamie Z; Mpintoudi A; Milonakis N; Kenanidis E; Tsiridis E
    Cureus; 2024 Jan; 16(1):e52171. PubMed ID: 38344527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
    Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
    Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open versus arthroscopic surgery for diffuse tenosynovial giant-cell tumours of the knee: a systematic review.
    Quaresma MB; Portela J; Soares do Brito J
    EFORT Open Rev; 2020 Jun; 5(6):339-346. PubMed ID: 32655889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computed Tomography Findings of Pigmented Villonodular Synovitis in a Dog.
    Dempsey LM; Maddox TW; Meiring T; Wustefeld-Janssens B; Comerford EJ
    Vet Comp Orthop Traumatol; 2018 Jul; 31(4):304-310. PubMed ID: 29864767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigmented villonodular synovitis of the knee: A retrospective analysis of 214 cases at a UK tertiary referral centre.
    Patel KH; Gikas PD; Pollock RC; Carrington RW; Cannon SR; Skinner JA; Briggs TW; Aston WJS
    Knee; 2017 Aug; 24(4):808-815. PubMed ID: 28442184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.